| Description | This is a neutralizing antibody specific for LASV GPC (Lassa virus glycoprotein precursor). It targets residues essential for LAMP1 binding and residues in the GP2 fusion loop. It potently neutralizes multiple LASV. This product has been tested by Enzyme-linked immunosorbent assay and Neutralization assay. |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | Lassa virus (LASV) |
| Epitope | Residues essential for LAMP1 binding and residues in the GP2 fusion loop |
| Neutralization Mechanism | It targets residues essential for LAMP1 binding and residues in the GP2 fusion loop. |
| Isotype | IgG |
| Expression Species | HEK293F or CHO cell |
| Purity | >95%, determined by SDS-PAGE and SEC-HPLC |
| Endotoxin | <1 EU/mg |
| Form | Liquid |
| Purification | Protein A purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics. |
| Application | ELISA; Neut |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | LASV GPC |
| Alternative Name | Lassa virus glycoprotein precursor |
| Research Area | Infectious Disease |
| Related Disease | Lassa hemorrhagic fever |
